Phillip Schwartz

Insider Reports History

Location
Jerusalem, Israel
Signature
/s/ Dana Yaacov-Garbeli, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Phillip Schwartz:

Company Role Class Num Shares Value Price $ Report Date Ownership
Entera Bio Ltd. President of R&D, Director Ordinary Shares, par value NIS 0.0000769 per share 607,410 $601,336 $0.9900 20 Jan 2022 Direct

Insider Reports Filed by Phillip Schwartz

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ENTX Entera Bio Ltd. 20 Jan 2022 1 +$25,250 4 President of R&D, Director 24 Jan 2022, 15:17
ENTX Entera Bio Ltd. 01 Jan 2022 0 $0 3 President of R&D, Director 11 Jan 2022, 15:04
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .